Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,600.00
+20.00 (0.78%)
At close: Mar 6, 2026

Prestige Biologics Ratios and Metrics

Millions KRW. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
192,438283,797245,391272,542184,546453,181
Upgrade
Market Cap Growth
-46.83%15.65%-9.96%47.68%-59.28%-
Upgrade
Enterprise Value
275,801364,568378,645369,331283,846447,789
Upgrade
Last Close Price
2475.003650.003990.004460.003020.009600.00
Upgrade
PS Ratio
10.0022.64113.13156.1111855.95140.44
Upgrade
PB Ratio
1.692.103.422.731.574.24
Upgrade
P/TBV Ratio
1.712.123.462.761.584.31
Upgrade
EV/Sales Ratio
14.3329.09174.57211.5518235.34138.77
Upgrade
Debt / Equity Ratio
0.740.682.411.601.010.73
Upgrade
Net Debt / Equity Ratio
0.730.672.001.150.880.39
Upgrade
Net Debt / EBITDA Ratio
-4.09-4.36-6.47-3.62-3.60-1.80
Upgrade
Net Debt / FCF Ratio
-17.44-3.82-8.51-1.90-0.87-0.34
Upgrade
Asset Turnover
0.070.050.01-00.03
Upgrade
Inventory Turnover
1.221.280.89-0.000.14
Upgrade
Quick Ratio
0.060.060.340.530.541.59
Upgrade
Current Ratio
0.320.400.600.790.921.93
Upgrade
Return on Equity (ROE)
-22.14%-26.55%-34.26%--44.30%-74.70%
Upgrade
Return on Assets (ROA)
-7.76%-7.52%-7.02%--9.85%-13.05%
Upgrade
Return on Capital Employed (ROCE)
-24.60%-20.10%-17.00%-18.50%-16.20%-15.00%
Upgrade
Earnings Yield
-14.67%-9.68%-11.97%-14.47%-26.94%-8.69%
Upgrade
FCF Yield
-2.48%-8.29%-6.87%-22.11%-64.36%-27.17%
Upgrade
Buyback Yield / Dilution
-34.27%-20.50%-4.32%-13.35%-16.43%-25.46%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.